Dr. Han is interested in understanding the influence of genetic and environmental factors on the etiology and prevention of skin lesions. His genetic epidemiological research started with the etiology of skin cancers and expanded to other skin lesions such as psoriasis, moles, and acne. Besides a series of genetic susceptibility investigation, he has also conducted a great deal of epidemiological research to identify lifestyle and environmental risk factors and comorbidities for skin cancers, psoriasis, and acne. Currently he leads post-GWAS collaborative projects examining the biological function of genetic variants using bioinformatics and molecular biology tools. In addition to a series of newly identified genetic markers for human pigmentation and skin cancers, he recently has conducted cancer network research. He has also played a leading role in large national and international collaborative consortia on melanoma, non-melanoma skin cancer, and human pigmentation. He has also worked on breast, endometrial and lung cancers. In addition, he serves as a key investigator on multiple NIH-funded projects, providing critical expertise in genetic and molecular epidemiology to other faculty members and researchers. He has been the Principal Investigator on a dozen of NIH grants. He has published over 160 original research articles in peer-reviewed journals. He has been invited to speak about his research at regional, national, and international scientific meetings. He has served as ad hoc reviewer for over 100 peer-reviewed scientific journals and is currently an Associate Editor for the journal Cancer Causes and Control. He also serves on the editorial board of Experimental Dermatology and has acted as Guest Associate Editor of PLoS Genetics. Dr. Han has served on a number of national and international committees and grant review panels in the NIH study sections, the U.S. Department of Defense, and the American Cancer Society. He has been on several committees and chaired sessions of national and international scientific societies.
I am interested in understanding the influence of genetic and environmental factors in the etiology and prevention of skin lesions, particularly skin cancer. Initially, I was engaged in studies of inherited susceptibility to skin cancers, focusing on DNA repair and related genes. I then moved from candidate genes to multiple candidate molecular pathways, including cell cycle, pigmentation, immunity, telomere, and microRNA biosynthesis. Beyond the candidate gene and pathway approach, I am also conducting a series of genome-wide association studies (GWAS) to identify novel loci on pigmentation, nevogenesis, skin cancers, and several other related phenotypes and outcomes. Currently, I am conducting post-GWAS research projects examining the biological function of top significant variants identified from GWAS and integrating the gene expression profile for pathway enrichment evaluation. Meanwhile, I have expanded my research on the etiology of skin cancer to other skin lesions such as psoriasis. Besides genetic susceptibility, I have expanded my research to identify lifestyle and environmental risk factors for skin cancers and psoriasis.
Daniel Mark Siegel, M.D. is a board-certified dermatologist, Mohs surgeon and President of the American Academy of Dermatology. Dr. Daniel M. Siegel also serves as Clinical Professor of Dermatology at the State University of New York (SUNY) at Downstate School of Medicine, directs the American College of Graduate Medical Education (ACGME) approved Procedural Dermatology Fellowship and the American College of Mohs Surgery training program, and spends part of his week at the Brooklyn Veterans Administration (VA) Hospital. He currently is member of the Board of Directors of both the American Academy of Dermatology and the American College of Mohs Surgery. Born and raised in New York, Dr. Siegel is a graduate of Stuyvesant High School (often called the best high school in America). After this he attended Rensselaer Polytechnic Institute where he received his magna cum laude undergraduate education as part of a combined six year biomedical program with Albany Medical College from which he received his Doctor of Medicine Degree in 1981. Following graduation, he was an internal medicine intern at Albany Medical Center Hospital and then went on to perform a dermatology residency at the University of Texas Southwestern Medical Center – Parkland Memorial Hospital in Dallas, Texas, where he rose to become chief resident in his final year before his Fellowship in Mohs Micrographic Surgery and Dermatologic Surgery at Baylor. After his Fellowship, he returned to the University of Texas Southwestern Medical Center – Parkland Memorial Hospital in Dallas, Texas, where he founded and ran that institution’s first Mohs and Dermatologic Surgery unit. Dr. Siegel has received many honors including the AAD Presidential Citation for exceptional contributions to the Academy and the field of dermatology.
Mohs Micrographic Surgery, Dermatologic Surgery
Dr. Kathryn Leake completed her PhD at the age of 45 years from The University of North Texas Health Science Center and a Postdoctoral Fellowship from Université Laval at Centre de Rechérche de Centre Hospitalier Universital de Quebec. She is Director of Oncology Solutions, a philanthropic organization that develops drugs for rare cancers. She has provisional patents on treatments for more than 8 malignancies, and several publications in reputed journals. She also serves as an editorial board member of Insights in Blood Pressure.
Dr. Sirakov has earned his B.S. and Master degrees from the School of Mathematics and Informatics Sofia University in 1983, and his Ph.D. degree in Mathematics/CS in 1991 from Center of Mathematics Computer Science and Mechanics-Bulgarian Academy of Sciences (BAS). He has worked for Institute of Mechanics and Biomechanics-BAS until 1999 as a research fellow and Associate Professor, CVRM-Instituto Superior Tecnico Portugal 1993/1994 and 1998-2000 under EU and NATO research projects. He taught lectures for Technical University of Sofia, Transport University-Bulgaria, Northern Arizona University 2001-2004. Since 2004 he is with Department of Computer Science and Department of Mathematics at Texas A&M University – Commerce. Dr. Sirakov’s research interests fall in Active Contours development, Geometric and Semantic Features extraction, Classification and Recognition, 3D Reconstruction and Visualization. The recent areas of application of his expertise are automatic weapons identification with the help of ontology, automatic skin lesion features extraction and skin cancer identification. In the above mentioned field and applications he has published 100 papers and co-authored in two books. He is reviewing for a number of journals and symposiums.
Skin Lesion, Skin Cancer, Ontology
Dr. Shang Jing is the academic leader of State Key Laboratory of Natural Medicines. She has published 100 papers, including 24 SCI papers in journals of pharmacology and related fields such as Hepatology, Free Radic Biol Med and Diabetes Metab Res Rev. She owns seven patents and completes the preclinical study of three Chinese traditional medicines and natural drugs.
Dr. Shang Jing is a professor of pharmacology working on the evaluation of natural medicine for decades. Her initial interest started in 2000 when she accomplished her PhD degree in Free University of Berlin in Germany. Nowadays, her major research field is to find the new way to discover the biological function and screen the bioactive compounds of natural medicines to cure the skin disorders and metabolic disorders, with the systems biology theory and modern molecular biology techniques. She is the first person who discovered the effective parts of Vernonia anthelmintica (L.), which is an ethnomedicine to cure vitiligo. She also found the new clinical application of the antidepressant fluoxetine by controlling the synthesis of melanin via the nervous system directly and indirectly.
Hana Zelenková has been active in the field of Dermatovenerology since 1973. Since 2000 she has been directing her own Private Clinic of Dermatovenereology. Professional orientation: aesthetic dermatology, acne and facial dermatoses, medicinal mycology (nail diseases), wound management, psoriasis, employment of Ichthyol and carboxytherapy in dermatology. She is a coordinator of many international multicentre trials. More than 555 expert lectures in the Slovak Republic as well as abroad, 440 scientific publications. Co-author of the dermatocosmetic formulae containing Ichthamol and glycyrrhizinic acid. Author of the book “Carboxytherapy” (2015), translated into 4 languages. Regularly invited to deliver lectures at international congresses. Founder and President of the Slovak Society for Aesthetic and Cosmetic Dermatology (SSEDK), organizer and President of the traditional international DERMAPARTY congress. Since 2006 Vice-President European Society of Aesthetic and Cosmetic Dermatology, since 2007 President of the European Society of Aesthetic and Cosmetic Dermatology.
Dermatovenerology, Cosmetic Dermatology, Aestheti, acne and facial dermatoses,medicinal mycology , wound management, psoriasis, employment of Ichthyol and carboxytherapy in dermatology
Dr. Navid Ezra is a dermatologist in Woodland Hills, California. He received his medical degree from David Geffen School of Medicine at UCLA and has been in practice between 3-5 years.
Dermatology, Dermatologists diagnose and treat diseases of the skin and perform cosmetic procedures, including hair removal, laser therapy, cosmetic filler injections, cryosurgery, tattoo removal, and phototherapy.
Chang Chung Hsing is a doctor of dermatology. She is a professor in the department Of dermatology, KMU.
Clinical dermatology, Skin physiology, Cutaneous immunology and Developmental biology Carcinogenesis
Dr.Sobanko is board-certified in dermatology and specializes in all aspects of dermatologic surgery, with special emphasis on Mohs micrographic surgery for skin cancer, reconstructive surgery, laser surgery and cosmetic dermatology. His research investigates the importance of physical appearance and how its alteration can significantly impact the lives of patients. Additional research interests of his include scar revision, laser skin resurfacing and minimally-invasive cosmetic procedures, such as soft tissue fillers and botulinum toxin. Dr. Sobanko is the Director of Dermatologic Surgery Education at The University of Pennsylvania, one of the premier academic institutions in the country, where he trains medical students, residents, and fellows. Dr. Sobanko has published over 30 scientific articles, 7 textbook chapters, and is currently in the process of authoring his own textbook. Dr. Sobanko lectures nationally and his expertise has been cited in media outlets such as Time Magazine, NBC Today Show, and Los Angeles Times.
Mohs micrographic surgery for skin cancer, reconstructive surgery, laser surgery and cosmetic dermatology
Hugo Arturo Cejas is a Doctor of Medicine and Surgery. He has worked as DePatologia Professor from 1990-2007, National University of Cordoba, Argentina, Faculty of Medicine Director of the Graduate School of the Faculty of Medicine from 2005-2006 and Director of the Journal of the Medical Faculty from 1999-2002.
Medicine and Surgery
Dr. Esche is a board-certified dermatologist and founder of The Beautiful Skin Institute in Northern Virginia. He has received more than 10 academic awards for his research and has authored more than 70 scientific publications. Dr. Esche became the National Winner of the Doctor’s Choice Award in Dermatology in 2014 and again in 2015.